Testing effectiveness (Phase 2)Looking for participantsNCT07025889What this trial is testingIBI343 Combined With Sintilimab Plus Chemotherapy in Gastric CancerWho this might be right forGastric Cancer Ruijin Hospital 55
Testing effectiveness (Phase 2)Ended earlyNCT00539617What this trial is testingChemotherapy & Erlotinib in Treating Patients w/ Esophageal or Gastroesophageal Cancer That Cannot Be Removed by SurgeryWho this might be right forEsophageal Cancer University of California, San Francisco 7
Testing effectiveness (Phase 2)Study completedNCT02730546What this trial is testingPembrolizumab, Combination Chemotherapy, and Radiation Therapy Before Surgery in Treating Adult Patients With Locally Advanced Gastroesophageal Junction or Gastric Cardia Cancer That Can Be Removed by SurgeryWho this might be right forGastric Cardia AdenocarcinomaGastroesophageal Junction AdenocarcinomaStage IB Gastric Cancer AJCC v7+5 more Mayo Clinic 31
Large-scale testing (Phase 3)Not Yet RecruitingNCT06944496What this trial is testingDisitamab Vedotin Combined With Tislelizumab and Chemotherapy Versus Tislelizumab Combined With Chemotherapy in HER2-Low Advanced Gastric or Gastroesophageal Junction AdenocarcinomaWho this might be right forGastric Carcinoma RemeGen Co., Ltd. 616
Early research (Phase 1)Active Not RecruitingNCT05156866What this trial is testingFirst in Human Study of TORL-2-307-ADC in Participants With Advanced CancerWho this might be right forAdvanced Solid TumorGastric CancerPancreas Cancer+1 more TORL Biotherapeutics, LLC 163
Testing effectiveness (Phase 2)WithdrawnNCT05678205What this trial is testingA Clinical Trial of the Safety and Anti-Tumor Activity of AB-201 in Subjects With Advanced HER2+ Solid TumorsWho this might be right forBreast CancerGastric CancerGastroesophageal Junction Adenocarcinoma Artiva Biotherapeutics, Inc.
Early research (Phase 1)Enrolling By InvitationNCT07218003What this trial is testingA Phase 1/1b of RNDO-564 Single Agent or in Combination With Pembrolizumab in Bladder Cancer and Other Solid Tumors Associated With Nectin-4Who this might be right forNon Small Cell Lung CancerCervical CancerHead and Neck Squamous Cell Cancer+7 more Rondo Therapeutics 149
Testing effectiveness (Phase 2)Study completedNCT01472029What this trial is testingExplorative Phase II Study of Perioperative Treatment in Patients With Adenocarcinoma of the Gastroesophageal Junction or StomachWho this might be right forAdenocarcinoma of the Gastroesophageal JunctionAdenocarcinoma of the Stomach AIO-Studien-gGmbH 53
Testing effectiveness (Phase 2)Study completedNCT03929666What this trial is testingA Safety and Efficacy Study of ZW25 (Zanidatamab) Plus Combination Chemotherapy in HER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal CancerWho this might be right forHER2-expressing Gastrointestinal Cancers, Including Gastroesophageal Adenocarcinoma, Biliary Tract Cancer, and Colorectal Cancer Jazz Pharmaceuticals 74
Testing effectiveness (Phase 2)Ended earlyNCT05311176What this trial is testingIMU-131 (HER-Vaxx) in Combination With Chemotherapy or Pembrolizumab in Patients With Metastatic HER2/Neu Over-Expressing Gastric Cancer (nextHERIZON)Who this might be right forGastric CancerCancer of StomachGastric Adenocarcinoma+3 more Imugene Limited 7
Post-approval studies (Phase 4)Not Yet RecruitingNCT07801027What this trial is testingA Trial of Pembrolizumab With Chemotherapy or Chemoradiotherapy in Participants From India With Different Types of Cancer (MK-3475-G44/KEYNOTE-G44)Who this might be right forNeoplasm MalignantGastric NeoplasmsGastroesophageal Junction Adenocarcinoma+2 more Merck Sharp & Dohme LLC 150
Testing effectiveness (Phase 2)Study completedNCT01630083What this trial is testingEfficacy and Safety of IMAB362 in Combination With the EOX Regimen for CLDN18.2-positive Gastric CancerWho this might be right forCLDN18.2-positive Adenocarcinoma of the Gastroesophageal JunctionCLDN18.2-positive Adenocarcinoma of EsophagusCLDN18.2-positive Gastric Adenocarcinoma Astellas Pharma Global Development, Inc. 252
Testing effectiveness (Phase 2)Not Yet RecruitingNCT06469060What this trial is testingNeoadjuvant Immunochemotherapy for Adenocarcinoma of the Esophagogastric JunctionWho this might be right forEsophageal Cancer Shanghai Chest Hospital 34
Not applicableUnknownNCT04675138What this trial is testingDevelopment of a Clinical Decision Support System With Artificial Intelligence for Cancer CareWho this might be right forGastric CancerEsophageal CancerEsophagogastric Junction Cancer National University Hospital, Singapore 1,000
Testing effectiveness (Phase 2)UnknownNCT04077255What this trial is testingEGFR-targeted Therapy for Gastric CancerWho this might be right forAdenocarcinoma of the Stomach National Cancer Center, Korea 19
Testing effectiveness (Phase 2)UnknownNCT04792515What this trial is testingCamrelizumab Combined With SOX and/or Apatinib for Locally Advanced Gastric CancerWho this might be right forLocally Advanced Gastric Cancer First Affiliated Hospital Xi'an Jiaotong University 67
Testing effectiveness (Phase 2)Active Not RecruitingNCT05480384What this trial is testingAdjuvant Trastuzumab Deruxtecan (Enhertu) & Nivolumab For Patients Who Are Disease Free After Completion of Trimodality Treatment For HER-2+ Cancers of Esophagus & Gastroesophageal JunctionWho this might be right forEsophageal AdenocarcinomaEsophageal CancerHER-2 Protein Overexpression+1 more Brown University 1
Testing effectiveness (Phase 2)UnknownNCT02525237What this trial is testingApatinib in Combination With S-1 as First-Line Treatment in Patients With Advanced Gastric CancerWho this might be right forGastric Cancer Qingdao Municipal Hospital 30
Testing effectiveness (Phase 2)WithdrawnNCT00620607What this trial is testingHuC242-DM4 Treating Patients With Metastatic Gastric or Gastroesophageal Junction CarcinomasWho this might be right forStomach NeoplasmsMetastatic or Locally Advanced Gastric CancerMetastatic or Local Advanced GE Junction Cancer ImmunoGen, Inc.
Testing effectiveness (Phase 2)Study completedNCT00006081What this trial is testingCombination Chemotherapy in Treating Patients With Unresectable Locally Advanced or Metastatic Stomach CancerWho this might be right forEsophageal CancerGastric Cancer M.D. Anderson Cancer Center 37